Suppr超能文献

用于临床应用的脐带组织源间充质干细胞的分离与增殖

Isolation and proliferation of umbilical cord tissue derived mesenchymal stem cells for clinical applications.

作者信息

Van Pham Phuc, Truong Nhat Chau, Le Phuong Thi-Bich, Tran Tung Dang-Xuan, Vu Ngoc Bich, Bui Khanh Hong-Thien, Phan Ngoc Kim

机构信息

Laboratory of Stem Cell Research and Application, University of Science, Vietnam National University, Ho Chi Minh City, Vietnam.

Van Hanh Stem Cell Unit, Van Hanh Hospital, Ho Chi Minh City, Vietnam.

出版信息

Cell Tissue Bank. 2016 Jun;17(2):289-302. doi: 10.1007/s10561-015-9541-6. Epub 2015 Dec 17.

Abstract

Umbilical cord (UC) is a rich source of rapidly proliferating mesenchymal stem cells (MSCs) that are easily cultured on a large-scale. Clinical applications of UC-MSCs include graft-versus-host disease, and diabetes mellitus types 1 and 2. UC-MSCs should be isolated and proliferated according to good manufacturing practice (GMP) with animal component-free medium, quality assurance, and quality control for their use in clinical applications. This study developed a GMP standard protocol for UC-MSC isolation and culture. UC blood and UC were collected from the same donors. Blood vasculature was removed from UC. UC blood was used as a source of activated platelet rich plasma (aPRP). Small fragments (1-2 mm(2)) of UC membrane and Wharton's jelly were cut and cultured in DMEM/F12 medium containing 1 % antibiotic-antimycotic, aPRP (2.5, 5, 7.5 and 10 %) at 37 °C in 5 % CO2. The MSC properties of UC-MSCs at passage 5 such as osteoblast, chondroblast and adipocyte differentiation, and markers including CD13, CD14, CD29, CD34, CD44, CD45, CD73, CD90, CD105, and HLA-DR were confirmed. UC-MSCs also were analyzed for karyotype, expression of tumorigenesis related genes, cell cycle, doubling time as well as in vivo tumor formation in NOD/SCID mice. Control cells consisted of UC-MSCs cultured in DMEM/F12 plus 1 % antibiotic-antimycotic, and 10 % fetal bovine serum (FBS). All UC-MSC (n = 30) samples were successfully cultured in medium containing 7.5 and 10 % aPRP, 92 % of samples grew in 5.0 % aPRP, 86 % of samples in 2.5 % aPRP, and 72 % grew in 10 % FBS. UC-MSCs in these four groups exhibited similar marker profiles. Moreover, the proliferation rates in medium with PRP, especially 7.5 and 10 %, were significantly quicker compared with 2.5 and 5 % aPRP or 10 % FBS. These cells maintained a normal karyotype for 15 sub-cultures, and differentiated into osteoblasts, chondroblasts, and adipocytes. The analysis of pluripotent cell markers showed UC-MSCs maintained the expression of the oncogenes Nanog and Oct4 after long term culture but failed to transfer tumors in NOD/SCID mice. Replacing FBS with aPRP in the culture medium for UC tissues allowed the successful isolation of UC-MSCs that satisfy the minimum standards for clinical applications.

摘要

脐带(UC)是快速增殖的间充质干细胞(MSC)的丰富来源,易于大规模培养。脐带间充质干细胞的临床应用包括移植物抗宿主病以及1型和2型糖尿病。脐带间充质干细胞应按照良好生产规范(GMP),使用无动物成分的培养基进行分离和增殖,并进行质量保证和质量控制,以用于临床应用。本研究制定了脐带间充质干细胞分离和培养的GMP标准方案。从同一供体收集脐带血和脐带。去除脐带中的血管系统。脐带血用作活化富血小板血浆(aPRP)的来源。将脐带膜和华通氏胶切成小碎片(1-2平方毫米),在含有1%抗生素-抗真菌剂、aPRP(2.5%、5%、7.5%和10%)的DMEM/F12培养基中,于37°C、5%二氧化碳条件下培养。对第5代脐带间充质干细胞的成骨细胞、软骨细胞和脂肪细胞分化等MSC特性以及包括CD13、CD14、CD29、CD34、CD44、CD45、CD73、CD90、CD105和HLA-DR在内的标志物进行了确认。还对脐带间充质干细胞的核型、肿瘤发生相关基因的表达、细胞周期、倍增时间以及在NOD/SCID小鼠体内的肿瘤形成进行了分析。对照细胞为由在DMEM/F12加1%抗生素-抗真菌剂和10%胎牛血清(FBS)中培养的脐带间充质干细胞组成。所有脐带间充质干细胞(n = 30)样本在含有7.5%和10% aPRP的培养基中均成功培养;92%的样本在5.0% aPRP中生长;86%的样本在2.5% aPRP中生长;72%的样本在10% FBS中生长。这四组中的脐带间充质干细胞表现出相似的标志物谱。此外,与2.5%和5% aPRP或10% FBS相比,含PRP培养基中的增殖率,尤其是7.5%和10% aPRP中的增殖率明显更快。这些细胞在15次传代培养中保持正常核型,并分化为成骨细胞、软骨细胞和脂肪细胞。多能细胞标志物分析表明,脐带间充质干细胞在长期培养后维持了原癌基因Nanog和Oct4的表达,但在NOD/SCID小鼠中未形成肿瘤。在脐带组织培养基中用aPRP替代FBS可成功分离出符合临床应用最低标准的脐带间充质干细胞。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验